AraC

DRUG5 trials

Sponsors

Groupe d'etude et de travail sur les leucemies aigues promyelocytaires, Goethe University, University of California, San Diego, Shandong University, Masonic Cancer Center, University of Minnesota

Conditions

AMLAcute Lymphocytic LeukemiaAcute Myeloid LeukemiaAdult Lymphoblastic LymphomaHodgkin LymphomaLeukemia, Promyelocytic, AcuteNon-Hodgkin Lymphoma

Phase 2

Imatinib + MTC in Relapsed / Refractory Acute Myeloid Leukemia (AML)

CompletedNCT00744081

Goethe UniversityAML

Start: 2004-07-31End: 2010-12-31Target: 130Updated: 2023-03-10

Chemotherapy With Liposomal Cytarabine CNS Prophylaxis for Adult Acute Lymphoblastic Leukemia & Lymphoblastic Lymphoma

TerminatedNCT02043587

University of California, San DiegoAcute Lymphocytic Leukemia, Adult Lymphoblastic Lymphoma

Start: 2014-01-31End: 2022-04-14Updated: 2022-05-02

Clinical Trial of Ara-C, Aclarubicin Combined With PEG-G-CSF for Initial Treatment of AML Patients

Shandong UniversityAcute Myeloid Leukemia

Start: 2017-01-31End: 2020-07-31Target: 120Updated: 2017-02-07

Auto Stem Cell Transplant for Lymphoma Patients

RecruitingNCT03125642

Masonic Cancer Center, University of MinnesotaHodgkin Lymphoma, Non-Hodgkin Lymphoma

Start: 2017-04-20End: 2027-04-30Target: 150Updated: 2025-11-04

Phase 3

A Randomized Trial Assessing the Roles of AraC in Newly Diagnosed APL Promyelocytic Leukemia (APL)

CompletedNCT00591526

Groupe d'etude et de travail sur les leucemies aigues promyelocytairesLeukemia, Promyelocytic, Acute

Start: 2000-06-30End: 2004-06-30Updated: 2008-01-14

Related Papers

A Phase II Study of Pegylated Asparaginase, Cyclophosphamide, Rituximab, and Dasatinib Added to the UCSF 8707 (Linker 4-drug) Regimen with Liposomal Cytarabine CNS Prophylaxis for Adults with Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL): University of California Hematologic Malignancies Consortium Study (UCHMC) 1401

Blood2018-11-297 citations